Hypoxia-inducing cryogels uncover key cancer-immune cell interactions in an oxygen-deficient tumor microenvironment.
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
10 Jan 2023
10 Jan 2023
Historique:
entrez:
30
1
2023
pubmed:
31
1
2023
medline:
31
1
2023
Statut:
epublish
Résumé
Hypoxia, an important feature of solid tumors, is a major factor shaping the immune landscape, and several cancer models have been developed to emulate hypoxic tumors. However, to date, they still have several limitations, such as the lack of reproducibility, inadequate biophysical cues, limited immune cell infiltration, and poor oxygen (O
Identifiants
pubmed: 36711715
doi: 10.1101/2023.01.10.523477
pmc: PMC9882080
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NIBIB NIH HHS
ID : R01 EB027705
Pays : United States
Commentaires et corrections
Type : UpdateIn
Références
Front Oncol. 2021 Jul 29;11:700407
pubmed: 34395270
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Genes Dev. 1998 Jan 15;12(2):149-62
pubmed: 9436976
Philos Ethics Humanit Med. 2009 Jan 15;4:2
pubmed: 19146696
PLoS One. 2016 May 24;11(5):e0155921
pubmed: 27219067
Cancer Metastasis Rev. 2007 Jun;26(2):225-39
pubmed: 17440684
Oncoimmunology. 2017 Jan 19;6(4):e1283468
pubmed: 28507790
Adv Sci (Weinh). 2021 Jul 20;8(18):2100316
pubmed: 34580619
Arch Med Sci. 2018 Jun;14(4):910-919
pubmed: 30002710
Cancers (Basel). 2019 Nov 13;11(11):
pubmed: 31766201
Cancer Res. 2015 Jul 15;75(14):2775-87
pubmed: 25977333
Nat Rev Immunol. 2005 Sep;5(9):712-21
pubmed: 16110315
Mater Today Bio. 2022 Jan 24;13:100207
pubmed: 35198956
Adv Med Sci. 2009;54(2):121-35
pubmed: 20022860
Crit Rev Oncol Hematol. 2021 Jun;162:103327
pubmed: 33862250
Front Immunol. 2018 Jul 16;9:1591
pubmed: 30061885
Am J Cancer Res. 2016 May 01;6(5):1078-88
pubmed: 27294000
Front Immunol. 2022 Feb 08;13:828875
pubmed: 35211123
Oncotarget. 2019 Jan 25;10(8):883-896
pubmed: 30783517
Front Mol Biosci. 2020 Mar 06;7:33
pubmed: 32211418
Biomater Sci. 2019 May 28;7(6):2264-2271
pubmed: 30849138
Reprod Toxicol. 2017 Sep;72:86-96
pubmed: 28552675
J Biotechnol. 2017 Apr 20;248:25-34
pubmed: 28284922
Adv Exp Med Biol. 2019;1136:123-139
pubmed: 31201721
Front Bioeng Biotechnol. 2021 Apr 12;9:660502
pubmed: 33912551
Lab Invest. 2012 Mar;92(3):362-70
pubmed: 22184093
Nat Rev Mater. 2016 Dec;1(12):
pubmed: 29657852
Signal Transduct Target Ther. 2018 Sep 28;3:26
pubmed: 30275987
Crit Rev Immunol. 2014;34(5):359-88
pubmed: 25404045
Annu Rev Biomed Eng. 2017 Jun 21;19:163-194
pubmed: 28301735
Oncoimmunology. 2016 Sep 9;5(12):e1232236
pubmed: 28123871
Nat Commun. 2014 Jun 09;5:4075
pubmed: 24909742
Physiol Rev. 2011 Jan;91(1):221-64
pubmed: 21248167
Immunology. 2003 May;109(1):32-40
pubmed: 12709015
Carcinogenesis. 2014 Apr;35(4):840-8
pubmed: 24473118
ACS Biomater Sci Eng. 2015 Jul 13;1(7):481-493
pubmed: 26280020
J Exp Med. 2002 Jan 7;195(1):99-111
pubmed: 11781369
Adv Mater. 2016 Sep;28(35):7758-67
pubmed: 27417289
Science. 1956 Aug 10;124(3215):270-2
pubmed: 13351640
J Immunol Res. 2016;2016:5134329
pubmed: 26966693
Cell. 2007 Aug 24;130(4):601-10
pubmed: 17719539
Front Oncol. 2020 Apr 21;10:562
pubmed: 32373534
Nat Commun. 2015 Aug 12;6:7556
pubmed: 26265369
Acta Pharm Sin B. 2015 Sep;5(5):378-89
pubmed: 26579469
Materials (Basel). 2018 Aug 07;11(8):
pubmed: 30087295
Cancer Chemother Pharmacol. 2006 Dec;58(6):776-84
pubmed: 16532342
J Tissue Eng Regen Med. 2018 May;12(5):1238-1246
pubmed: 29489057
Proc Natl Acad Sci U S A. 2012 Nov 27;109(48):19590-5
pubmed: 23150549
Biomacromolecules. 2021 Oct 11;22(10):4110-4121
pubmed: 34514795
Nat Rev Mol Cell Biol. 2020 May;21(5):268-283
pubmed: 32144406
Micromachines (Basel). 2018 Dec 28;10(1):
pubmed: 30597832
Front Immunol. 2015 May 06;6:201
pubmed: 25999946
J Radiat Res. 2016 Aug;57 Suppl 1:i90-i98
pubmed: 26983987
Trends Immunol. 2019 Aug;40(8):699-718
pubmed: 31301952
Biosci Rep. 2018 Dec 14;38(6):
pubmed: 30463908
Sci Rep. 2015 Sep 01;5:13674
pubmed: 26323509
J Mol Med (Berl). 2016 Feb;94(2):155-71
pubmed: 26099350
Hypoxia (Auckl). 2015 Dec 11;3:83-92
pubmed: 27774485
Cancers (Basel). 2020 Nov 12;12(11):
pubmed: 33198125
Curr Biol. 2020 Aug 17;30(16):R921-R925
pubmed: 32810447
J Immunol. 2008 Apr 1;180(7):4697-705
pubmed: 18354193
Adv Healthc Mater. 2018 Jan;7(1):
pubmed: 29195022
Front Immunol. 2019 May 10;10:947
pubmed: 31134064
J Immunol. 2010 Jun 15;184(12):6790-8
pubmed: 20488796
Trends Biochem Sci. 2007 Jan;32(1):44-50
pubmed: 17158050
Nat Rev Cancer. 2011 Jun;11(6):393-410
pubmed: 21606941
Drug Resist Updat. 2021 Dec;59:100787
pubmed: 34840068
Clin Cancer Res. 2018 Oct 1;24(19):4798-4807
pubmed: 30084839
Physiology (Bethesda). 2021 Mar 1;36(2):73-83
pubmed: 33595388
J Cell Mol Med. 2010 Apr;14(4):771-94
pubmed: 20015196
Semin Immunol. 2016 Feb;28(1):54-63
pubmed: 26872631
Biomaterials. 2011 May;32(13):3423-34
pubmed: 21324403
Mater Today Adv. 2020 Dec;8:
pubmed: 34541484
Clin Cancer Res. 2008 Oct 1;14(19):5947-52
pubmed: 18829471
Blood. 2008 Nov 1;112(9):3723-34
pubmed: 18694997
J Cell Mol Med. 2021 Aug;25(16):7581-7592
pubmed: 34213838
J Res Med Sci. 2012 Jun;17(6):534-9
pubmed: 23626629
Free Radic Biol Med. 2010 Nov 1;49(8):1298-305
pubmed: 20673847
Biostatistics. 2019 Apr 1;20(2):273-286
pubmed: 29394327
J Leukoc Biol. 2008 Jul;84(1):134-42
pubmed: 18388297
Adv Exp Med Biol. 2019;1136:43-55
pubmed: 31201715
Front Immunol. 2020 Dec 10;11:603640
pubmed: 33362787
J Biol Chem. 1964 Nov;239:3927-34
pubmed: 14257628
Front Cell Dev Biol. 2019 Jan 29;7:4
pubmed: 30761299
J Immunol. 1998 Oct 1;161(7):3256-61
pubmed: 9759840
Biochimie. 2020 Sep;176:21-30
pubmed: 32585229
Front Immunol. 2021 Jan 20;11:613114
pubmed: 33552076
J Natl Cancer Inst. 2001 Feb 21;93(4):266-76
pubmed: 11181773
J Exp Clin Cancer Res. 2020 May 1;39(1):75
pubmed: 32357910
Science. 1956 Feb 24;123(3191):309-14
pubmed: 13298683
Nat Rev Cancer. 2014 Jun;14(6):430-9
pubmed: 24827502